Publication Cover
Synthetic Communications
An International Journal for Rapid Communication of Synthetic Organic Chemistry
Volume 3, 1973 - Issue 6
69
Views
16
CrossRef citations to date
0
Altmetric
Original Articles

Stereoselective Total Synthesis of Sesquiterpenoids: (+)-Sativene and (+)-Cyclosativene

, &
Pages 401-405 | Received 02 Oct 1973, Published online: 05 Dec 2006
 

Abstract

The well-known tricyclic sesquiterpenoid (−)-sativene, isolated in 1965 from Helminthosporium sativum and shown to possess structure and absolute configuration as indicated by structure 1 3, has been implicated3,4 as an intermediate in the biogenesis of the fungal toxin (−)-helminthosporal (2)5. Two total syntheses of the racemic modification of sativene have been reported6,7. A closely related sesquiterpenoid, (+)-cyclosativene, was isolated from Abies magnifica A. Murr. and was shown to possess structure 3 8,9. The absolute configuration of this material, although not established unambiguously, has been proposed10 as indicated by formula 3. The total synthesis of cyclosativene has not as yet been achieved directly, although it has been obtained indirectly via acid-promoted rearrangement of sativene8,9,11,12. We report herein a total synthesis of (+)-sativene (4) and (+)-cyclosativene (3) via a stereoselective route which unambiguously establishes the absolute configuration of both natural products.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.